Review Article

OPEN: An Epidemic Supplanted by a Pandemic: Vaping-Related Illness and COVID-19

Authors: Yoo Mee Shin, MD, Daniel P. Hunt, MD, Joyce Akwe, MD, MPH


Before the coronavirus disease 2019 (COVID-19) pandemic, vaping-related illness was the prevailing public health concern. The incidence of vaping-related illnesses—mainly e-cigarette, or vaping, product use–associated lung injury (EVALI)—went from a peak in September 2019 to a low in February 2020, and the Centers for Disease Control and Prevention decided to discontinue the collection of EVALI case reports. Despite the decrease in EVALI with the arrival of COVID-19, EVALI should still be considered a differential diagnosis for people with COVID-19 for reasons outlined in this review. This narrative review describes vaping devices, summarizes the adverse health effects of vaping on the lungs and other systems, considers the potential interplay between vaping and COVID-19, and highlights gaps in knowledge about vaping that warrant further research.

Posted in: Infectious Disease68 Pulmonary Disease16

Full Article

Having trouble viewing the article content below? Click here to open it directly.


Table. Effects of e-cigarettes on various organs and systems

Download Image


1. Orellana-Barrios MA, Payne D, Mulkey Z, et al. Electronic cigarettes—a narrative review for clinicians. Am J Med 2015;128:674–681.
2. Qasim H, Karim ZA, Rivera JO, et al. Impact of electronic cigarettes on the cardiovascular system. J Am Heart Assoc 2017;6:e006353.
3. Gentzke AS, Wang TW, Jamal A, et al. Tobacco product use among middle and high school students—United States, 2020. MMWR Morb Mortal Wkly Rep 2020;69:1881–1888.
4. Gilbert HJSn-tc. Inventor. 1963.
5. Bell K, Keane H. Nicotine control: e-cigarettes, smoking and addiction. Int J Drug Policy 2012;23:242–247.
6. Berg CJ, Barr DB, Stratton E, et al. Attitudes toward e-cigarettes, reasons for initiating e-cigarette use, and changes in smoking behavior after initiation: a pilot longitudinal study of regular cigarette smokers. Open J Prev Med 2014; 4:789–800.
7. Bhatnagar A, Whitsel LP, Ribisl KM, et al. Electronic cigarettes: a policy statement from the American Heart Association. Circulation 2014;130: 1418–1436.
8. Zhu S-H, Sun JY, Bonnevie E, et al. Four hundred and sixty brands of e-cigarettes and counting: implications for product regulation. Tob Control 2014;23(suppl 3):iii3–iii9.
9. Rose SW, Barker DC, D'Angelo H, et al. The availability of electronic cigarettes in US retail outlets, 2012: results of two national studies. Tob Control 2014;23(suppl 3):iii10–iii16.
10. Alberg AJ, Shopland DR, Cummings KM. The 2014 Surgeon General's report: commemorating the 50th Anniversary of the 1964 Report of the Advisory Committee to the US Surgeon General and updating the evidence on the health consequences of cigarette smoking. Am J Epidemiol 2014;179: 403–412.
11. Lushniak BD, Samet JM, Pechacek TF, et al. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention; 2014.
12. Wang TW, Gentzke AS, Creamer MR, et al. Tobacco product use and associated factors among middle and high school students—United States, 2019. MMWR Surveill Summ 2019;68:1–22.
13. Blount BC, Karwowski MP, Shields PG, et al. Vitamin E acetate in bronchoalveolar-lavage fluid associated with EVALI. N Engl J Med 2020; 382:697–705.
14. King BA, Patel R, Nguyen KH, et al. Trends in awareness and use of electronic cigarettes among US adults, 2010-2013. Nicotine Tob Res 2015; 17:219–227.
15. Brown CJ, Cheng JMJTc. Electronic cigarettes: product characterisation and design considerations. Tob Control 2014;23(suppl 2):ii4–ii10.
16. Dunlap D. An Original Survey Assessing E-Cigarette Regulation and Perceptions in all North Carolina Hospitals: A Research Design Proposal. Master's thesis, University of North Carolina, Chapel Hill; 2014.
17. Barrington-Trimis JL, Leventhal AM. Adolescents' use of "Pod Mod" e-cigarettes—urgent concerns. N Engl J Med 2018;379:1099–1102.
18. Fischer MH. The toxic effects of formaldehyde and formalin. J Exp Med 1905;6(4-6):487–518.
19. McGwin G Jr, Lienert J, Kennedy JI Jr. Formaldehyde exposure and asthma in children: a systematic review. Environ Health Perspect 2010; 118:313–317.
20. MacDonald A, Middlekauff HR. Electronic cigarettes and cardiovascular health: what do we know so far? Vasc Health Risk Manag 2019;15:159–174.
21. Peruzzi M, Biondi-Zoccai G, Carnevale R, et al. Vaping cardiovascular health risks: an updated umbrella review. Curr Emerg Hosp Med Rep 2020. DOI:10.1007/s40138-020-00219-0.
22. Farsalinos KE, Tsiapras D, Kyrzopoulos S, et al. Acute effects of using an electronic nicotine-delivery device (electronic cigarette) on myocardial function: comparison with the effects of regular cigarettes. BMC Cardiovasc Disord 2014;14:78.
23. Grana R, Benowitz N, Glantz SA. E-cigarettes: a scientific review. Circulation 2014;129:1972–1986.
24. Flora G, Gupta D, Tiwari A. Toxicity of lead: a review with recent updates. Interdiscip Toxicol 2012;5:47–58.
25. Abadin H, Ashizawa A, Llados F, et al. Toxicological Profile for Lead. Atlanta, GA: Agency for Toxic Substances and Disease Registry; 2007.
26. Lerner CA, Sundar IK, Yao H, et al. Vapors produced by electronic cigarettes and e-juices with flavorings induce toxicity, oxidative stress, and inflammatory response in lung epithelial cells and in mouse lung. PLoS One 2015;10: e0116732.
27. Sussan TE, Gajghate S, Thimmulappa RK, et al. Exposure to electronic cigarettes impairs pulmonary anti-bacterial and anti-viral defenses in a mouse model. PLoS One 2015;10:e0116861.
28. Faroon O, Roney N, Taylor J, et al. Acrolein health effects. Toxicol Ind Health 2008;24:447–490.
29. Schaller K., Ruppert L, Kahnert S, et al. Tobacco Prevention, Control T. Electronic Cigarettes–An Overview. Heidelberg: German Cancer Research Center; 2013.
30. Ellington S, Salvatore PP, Ko J, et al. Update: product, substance-use, and demographic characteristics of hospitalized patients in a nationwide outbreak of e-cigarette, or vaping, product use-associated lung injury—United States, August 2019-January 2020. MMWR Morb Mortal Wkly Rep 2020;69:44–49.
31. Moritz ED, Zapata LB, Lekiachvili A, et al. Update: characteristics of patients in a national outbreak of e-cigarette, or vaping, product useassociated lung injuries—United States, October 2019. MMWR Morb Mortal Wkly Rep 2019;68:985–989.
32. Hua M, Alfi M, Talbot PJJomIr. Health-related effects reported by electronic cigarette users in online forums. J Med Internet Res 2013;15:e59.
33. Callahan-Lyon P. Electronic cigarettes: human health effects. Tob Control 2014;23(suppl 2):ii36–40.
34. Jatlaoui TC, Wiltz JL, Kabbani S, et al. Update: interim guidance for health care providers for managing patients with suspected e-cigarette, or vaping, product use-associated Lung Injury—United States, November 2019. MMWR Morb Mortal Wkly Rep 2019;68:1081–1086.
35. Kligerman S, Raptis C, Larsen B, et al. Radiologic, pathologic, clinical, and physiologic findings of electronic cigarette or vaping product use-associated lung injury (EVALI): evolving knowledge and remaining questions. Radiology 2020;294:491–505.
36. Layden JE, Ghinai I, Pray I, et al. Pulmonary illness related to e-cigarette use in Illinois and Wisconsin - final report. N Engl J Med 2020;382:903–916.
37. Panse PM, Feller FF, Butt YM, et al. Radiologic and pathologic correlation in EVALI. Am J Roentgenol 2020;215:1057–1064.
38. Aberegg SK, Cirulis MM, Maddock SD, et al. Clinical, bronchoscopic, and imaging findings of e-cigarette, or vaping, product use–associated lung injury among patients treated at an academic medical center. JAMA Network Open 2020;3:e2019176.
39. Centers for Disease Control and Prevention. Outbreak of lung injury associated with the use of e-cigarette, or vaping, products. basic_information/e-cigarettes/severe-lung-disease.html#latest-information. Updated February 25, 2020. Accessed May 6, 2020.
40. Christiani DC. Vaping-induced acute lung injury. N Engl J Med 2020;382: 960–962.
41. Dinardo P, Rome ES. Vaping: the new wave of nicotine addiction. Cleve Clin J Med 2019;86:789–798.
42. Orr MS. Electronic cigarettes in the USA: a summary of available toxicology data and suggestions for the future. Tob Control 2014;23(suppl 2):ii18–ii22.
43. Wieslander G, Norback D, Lindgren T. Experimental exposure to propylene glycol mist in aviation emergency training: acute ocular and respiratory effects. Occup Environ Med 2001;58:649–655.
44. Williams M, Villarreal A, Bozhilov K, et al. Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. PLoS One 2013;8:e57987.
45. Reidel B, Radicioni G, Clapp PW, et al. E-cigarette use causes a unique innate immune response in the lung, involving increased neutrophilic activation and altered mucin secretion. Am J Respir Crit Care Med 2018;197:492–501.
46. Vardavas CI, Anagnostopoulos N, Kougias M, et al. Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide. Chest 2012;141:1400–1406.
47. Xantus GZ, Gyarmathy AV, Johnson CA. Smouldering ashes: burning questions after the outbreak of electronic cigarette or vaping-associated lung injury (EVALI). Postgrad Med J 2020;96:686–692.
48. Rodriguez JA, Roa AA, Lemos-Ramirez JC. E-cigarette or vaping product use-associated lung injury (EVALI) mimicking COVID-19 disease. Case Rep Pulmonol 2020;2020:8821289.
49. Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 2020;323:2052–2059.
50. Kichloo A, Khan A, Siddiqui N, et al. Habit mimics the illness: EVALI during the era of the COVID-19 pandemic. J Investig Med High Impact Case Rep 2020;8:2324709620972243.
51. Foust AM, Winant AJ, Chu WC, et al. Pediatric SARS, H1N1, MERS, EVALI, and now coronavirus disease (COVID-19) pneumonia: what radiologists need to know. AJR Am J Roentgenol 2020;215:736–744.
52. Ansari-Gilani K, Petraszko AM, Gilkeson RC. COVID-19 pneumonia versus EVALI, distinguishing the overlapping CT features in the COVID-19 era. Heart Lung 2020;49:885–886.
53. Callahan SJ, Harris D, Collingridge DS, et al. Diagnosing EVALI in the time of COVID-19. Chest 2020;158:2034–2037.
54. Gaiha SM, Cheng J, Halpern-Felsher B. Association between youth smoking, electronic cigarette use, and COVID-19. J Adolesc Health 2020; 67:519–523.